General practice

What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses

^a Health Economics Research Group, Brunel University, Uxbridge, Middlesex UB8 3PH, ^b Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, London WC1E 7HT

Correspondence to: Professor Buxton.

Abstract

Objectives: To provide a commentary on the economic evaluations of the Oxcheck and British family heart studies: direct comparison of their relative effectiveness and cost effectiveness; comparisons with other interventions; and consideration of problems encountered.
Design: Modelling from cost and effectiveness data to estimates of cost per life year gained.
Subjects: Middle aged men and women.
Interventions: Screening for cardiovascular risk factors followed by appropriate lifestyle advice and drug intervention in general practice, and other primary coronary risk management strategies.
Main outcome measures: Life years gained; cost per life year gained.
Results: Depending on the assumed duration of risk reduction, the programme cost per discounted life year gained ranged from £34 800 for a 1 year duration to £1500 for 20 years for the British family heart study and from £29 300 to £900 for Oxcheck. These figures exclude broader net clinical and cost effects and longer term clinical and cost effects other than coronary mortality.
Conclusions: Despite differences in underlying methods, the estimates in the two economic analyses of the studies can be directly compared. Neither study was large enough to provide precise estimates of the overall net cost. Modelling to cost per life year gained provides more readily interpretable measures. These estimates emphasise the importance of the relatively weak evidence on duration of effect. Only if the effect lasts at least five years is the Oxcheck programme likely to be cost effective. The effect must last for about 10 years to justify the extra cost associated with the British family heart study.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Lauritzen, T., Ager Jensen, M. S., Thomsen, J. L., Christensen, B., Engberg, M. (2008). Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs: An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scand J Public Health 36: 650-661 [Abstract]  
• Rasmussen, S. R., Thomsen, J. L., Kilsmark, J., Hvenegaard, A., Engberg, M., Lauritzen, T., Sogaard, J. (2007). Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scand J Public Health 35: 365-372 [Abstract]  
• Raftery, J. P, Yao, G. L, Murchie, P., Campbell, N. C, Ritchie, L. D (2005). Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care: follow up of a randomised controlled trial. BMJ 330: 707- [Abstract] [Full text]  
• Secker-Walker, R H, Holland, R R, Lloyd, C M, Pelkey, D, Flynn, B S (2005). Cost effectiveness of a community based research project to help women quit smoking. Tobacco Control 14: 37-42 [Abstract] [Full text]  
• Marshall, D. A., Levy, A. R., Vidaillet, H., Fenwick, E., Slee, A., Blackhouse, G., Greene, H. L., Wyse, D. G., Nichol, G., O'Brien, B. J., and the AFFIRM and CORE Investigators*, (2004). Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation. ANN INTERN MED 141: 653-661 [Abstract] [Full text]  
• Toop, L., Richards, D. (2001). Preventing cardiovascular disease in primary care. BMJ 323: 246-247 [Full text]  
• Steptoe, A., Doherty, S., Rink, E., Kerry, S., Kendrick, T., Hilton, S., Day, S. (1999). Behavioural counselling in general practice for the promotion of healthy behaviour among adults at increased risk of coronary heart disease: randomised trial • Commentary: Treatment allocation by the method of minimisation. BMJ 319: 943-948 [Abstract] [Full text]  
• van den Berg, P. J, van Dalsen, C. L, de Rooij, R. A., Prins, A., Hoes, A. W (1999). Cardiovascular health check in the elderly in one general practice: does it offer new information and lead to interventions?. Fam Pract 16: 389-394 [Abstract] [Full text]  
• Hilton, S., Doherty, S., Kendrick, T., Kerry, S., Rink, E., Steptoe, A. (1999). Promotion of healthy behaviour among adults at increased risk of coronary heart disease in general practice: methodology and baseline data from the Change of Heart study. Health Education Journal 58: 3-16 [Abstract]  
• UK Prospective Diabetes Study Group, (1998). Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317: 720-726 [Abstract] [Full text]  
• Florin, D. (1996). Barriers to evidence based policy. BMJ 313: 894-895 [Full text]  
• Muir, J., Jones, L., Fowler, G. (1996). Cost effectiveness of health checks. BMJ 313: 624-624 [Full text]  
• Graham, J. (1996). Factoring in effect on mortality from stroke increases cost effectiveness. BMJ 313: 624a-624 [Full text]  
• Smith, R. (1996). Rationing health care: moving the debate forward. BMJ 312: 1553-1554 [Full text]  
• Langham, S., Thorogood, M., Normand, C., Muir, J., Jones, L., Fowler, G. (1996). Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ 312: 1265-1268 [Abstract] [Full text]  
• Wonderling, D., McDermott, C., Buxton, M., Kinmonth, A.-L., Pyke, S., Thompson, S., Wood, D. (1996). Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ 312: 1269-1273 [Abstract] [Full text]